PGHL

** Shares of Procter & Gamble Health PROR.NS rise as much as 8.6% to 5,742.40 rupees, highest since May 28, 2021

** Pharma products maker reports 25.6% rise in Q1 net profit y/y to 823.3 mln rupees ($9.8 mln); rev grows 2.8%

** More than 79,000 shares traded, 11.4x the 30-day avg; busiest day since March 27

** PROR last up 7.3%, extending YTD gains of 17.8%

($1 = 84.1230 Indian rupees)

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

** India's Nifty 50 .NSEI and Sensex .BSESN drop about 0.2% each on profit-booking near record highs, and led by losses in consumer goods stocks

** Traders are booking profits after the recent record rally, and markets will remain rangebound due to lack of domestic triggers, analysts said

** Nifty FMCG index .NIFTYFMCG dropped 0.9% - top loser among 13 major sub-indexes - with all 15 constituents showing losses

** Dabur DABU.NS - the top pct loser on the index - fell 4.8% on a media report saying co's largest shareholders pulled out of buying stake in Coca-Cola KO.N India's bottling arm

** Seven of the 13 major sectoral indexes logged losses

** The more domestically-focussed Nifty mid-cap .NIFMDCP100 and small-cap .NIFMSCP100 slid 0.9% and 0.6%, respectively

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

May 2 (Reuters) - Procter & Gamble Health Ltd PROR.NS:

• PROCTER & GAMBLE HEALTH MARCH-QUARTER NET PROFIT 465.6 MILLION RUPEES VERSUS 591.9 MILLION RUPEES

• PROCTER & GAMBLE HEALTH MARCH-QUARTER REVENUE FROM OPERATIONS 2.52 BILLION RUPEES VERSUS 3.21 BILLION RUPEES

Source text for Eikon: ID:nBSE2wC68D

Further company coverage: PROR.NS

(([email protected];))

Nov 3 (Reuters) - Procter & Gamble Health Ltd PROR.NS:

• PROCTER & GAMBLE HEALTH LTD SEPT-QUARTER NET PROFIT 655.7 MILLION RUPEES VERSUS 636.6 MILLION RUPEES

• PROCTER & GAMBLE HEALTH LTD SEPT-QUARTER REVENUE FROM OPERATIONS 3.05 BILLION RUPEES VERSUS 2.98 BILLION RUPEES

Source text for Eikon: ID:nBSE5rK0Xy

Further company coverage: PROR.NS

(([email protected];))

Sept 27 (Reuters) - Procter & Gamble Health Ltd PROR.NS:

• PLANS TO SOURCE INJECTIONS PORTFOLIO OF ITS PRODUCTS FROM A CONTRACT MANUFACTURER

• COMPANY SHALL DISCONTINUE PRODUCTION OF INJECTIONS AT ITS MANUFACTURING PLANT IN GOA EFFECTIVE SEPT 30

• DISCONTINUATION OF PRODUCTION AT CO'S GOA PLANT SHALL NOT HAVE IMPACT ON CONTINUITY OF SALE OF INJECTIONS

Source text for Eikon: ID:nBSE4Vx6wn

Further company coverage: PROR.NS

(([email protected];;))

** Shares of Procter & Gamble Health PROR.NS down as much as 5.8% to 6-week low of 5,036.1 rupees

** Stock clocks biggest intraday pct loss since March 29 and on track for a fourth consecutive session of losses

** Pharma and healthcare products maker reported a nearly 28% fall June-quarter profit

** Total expenses jumps 7.4% on higher input, employee expenses

** Trading vol by 9:36 a.m. IST is 1.6x the 30-day avg

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

Aug 23 (Reuters) - Procter & Gamble Health Ltd PROR.NS:

• QUARTER WITNESSED CATEGORY SLOWDOWN ACROSS OUR PORTFOLIO

Source text for Eikon: ID:nBSE2xmd3f

Further company coverage: PROR.NS

(([email protected];))

BENGALURU, June 29 (Reuters) - Procter & Gamble India said it would invest 20 billion rupees ($243.79 million) to set up a personal healthcare manufacturing facility in the western state of Gujarat.

The company will manufacture digestive products that are part of parent P&G's global healthcare product portfolio at the facility, it said in a statement on Wednesday.

The facility will be operational in the next few years and become a global export hub for P&G, the Whisper sanitary napkin maker said.

The new facility spans 50,000 square meters in Sanand, Gujarat, and the investment is through an unlisted company and won't affect any listed public companies within the P&G group in India.

($1 = 82.0370 Indian rupees)

(Reporting by Navamya Ganesh Acharya in Bengaluru; Editing by Subhranshu Sahu)

(([email protected]; +91 8805175330 ;))

** Shares of Procter & Gamble Health Ltd PROR.NS rise as much as 3.40% to 4839 rupee, an one-month high

** Uptick after the pharma and healthcare products maker reports 16% Y/Y uptick in net profit in March quarter to 591.9 mln rupees

** Revenue from operations jumps 20% to 3.21 bln rupees in Q4

** Core profit rises 16% Y/Y to 796.6 mln rupees in March quarter

** Trading volume is 14,036 shares as of 12:01 p.m. IST, 1.4 times the 30-day avg - Refinitiv data

($1 = 81.7800 Indian rupees)

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463))